The gut microbiome in ARDS: from the "whether" and "what" to the "how"

Kale S Bongers¹, Kathleen A Stringer^{1

2

3}, Robert P Dickson^{1

3

4}

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA.
² Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
³ Weil Institute for Critical Care Research and Innovation, Ann Arbor, MI, USA.
⁴ Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.

Free article

Editorial

Kale S Bongers et al. Eur Respir J. 2023.

Free article

. 2023 Feb 16;61(2):2202233.

doi: 10.1183/13993003.02233-2022. Print 2023 Feb.

Kale S Bongers¹, Kathleen A Stringer^{1

2

3}, Robert P Dickson^{1

3

4}

¹ Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA.
² Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
³ Weil Institute for Critical Care Research and Innovation, Ann Arbor, MI, USA.
⁴ Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.

No abstract available

Conflict of interest statement

Conflict of interest: All authors have nothing to disclose.

Gut microbiota-derived succinate aggravates acute lung injury after intestinal ischaemia/reperfusion in mice.
Wang YH, Yan ZZ, Luo SD, Hu JJ, Wu M, Zhao J, Liu WF, Li C, Liu KX. Wang YH, et al. Eur Respir J. 2023 Feb 16;61(2):2200840. doi: 10.1183/13993003.00840-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36229053